Caribou Biosciences (CRBU) EPS (Basic) (2020 - 2026)
Caribou Biosciences' (CRBU) quarterly EPS (Basic) came in at -$0.29 in Q1 2026, up 36.85% year-on-year from -$0.21 in Q1 2025, and up 5.28% on a QoQ basis from -$0.31 in Q4 2025.
Caribou Biosciences (CRBU) EPS (Basic) (2020 - 2026) Analysis & Trends
Caribou Biosciences (CRBU) has 7 years of EPS (Basic) data on file, last reported at -$0.29 in Q1 2026.
- On a quarterly basis, EPS (Basic) rose 36.85% year-over-year to -$0.29 in Q1 2026; TTM through Mar 2026 was -$1.43, a 38.61% increase from a year earlier, with the FY2025 full-year figure at -$1.59, up 3.92% from the prior year.
- EPS (Basic) for Q1 2026 stood at -$0.29, up from -$0.31 in the prior quarter.
- Over the last five years, EPS (Basic) for CRBU reached as high as -$0.29 in Q1 2026 and fell as low as -$1.25 in Q2 2022.
- Historically, EPS (Basic) has averaged -$0.61 across 5 years, with a median of -$0.51 in 2022.
- Across the five-year window, EPS (Basic) surged 72.96% in 2022 and tumbled 135.92% in 2024, its largest moves.
- Year by year, EPS (Basic) stood at -$0.51 in 2022, then increased by 0.41% to -$0.51 in 2023, then gained by 12.32% to -$0.45 in 2024, then soared by 30.64% to -$0.31 in 2025, then rose by 5.28% to -$0.29 in 2026.
- Per Business Quant data, the three most recent EPS (Basic) figures were -$0.29 in Q1 2026, -$0.31 in Q4 2025, and -$0.35 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.16 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 0.00 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 0.00 |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 7.59 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -2.29 |
| 10 | Caribou Biosciences | 156.25 Mn | 38.63 Mn | - | -0.29 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.29 |
| Dec 31, 2025 | -0.31 |
| Sep 30, 2025 | -0.35 |
| Jun 30, 2025 | -0.51 |
| Mar 31, 2025 | -0.46 |
| Dec 31, 2024 | -0.45 |
| Sep 30, 2024 | -0.84 |
| Jun 30, 2024 | -0.63 |
| Mar 31, 2024 | -0.98 |
| Dec 31, 2023 | -0.51 |
| Sep 30, 2023 | -0.36 |
| Jun 30, 2023 | -1.25 |
| Mar 31, 2023 | -0.51 |
| Dec 31, 2022 | -0.51 |
| Sep 30, 2022 | -0.84 |
| Jun 30, 2022 | -1.25 |
| Mar 31, 2022 | -0.37 |
| Dec 31, 2021 | -0.58 |
| Sep 30, 2021 | -0.46 |
| Jun 30, 2021 | -1.39 |